Regeneron Pharmaceuticals Statistics
NASDAQ: REGNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
920.69-1.71 (-0.19%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Regeneron Pharmaceuticals by the numbers
Regeneron Pharmaceuticals has a market capitalization of $95.24 billion based on 101.63M shares outstanding. Its trailing P/E ratio is 20.4, below the 8-company peer median of 38.9, and its forward P/E is 12.8. The stock trades 11.0% above its 50-day average and 22.5% above its 200-day average.
Average daily trading volume is 805.45K shares, or about $741.6 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
REGN valuation vs. peer median
| Metric | REGN | Peer median | Difference |
|---|---|---|---|
| Market cap | $95.24B | $82.64B | +15% |
| P/E (TTM) | 20.4 | 38.9 | -48% |
| Forward P/E | 12.8 | 12.1 | +6% |
| Dividend yield | 0.40% | 4.29% | -91% |
| Avg. volume | 805.45K | 3.31M | -76% |
Peer median across 8 companies: GSK, SNY, BMY, TAK, VRTX, TEVA, ONC, RPRX.
Valuation
- Market cap
- $95.24B
- P/E (TTM)
- 20.35
- Forward P/E
- 12.85
- Price / sales (latest FY)
- 6.64
- EPS (TTM)
- $45.24
- Shares outstanding
- 101.63M
Price and trading
- Previous close
- 922.40
- Open
- 936.37
- Day range
- 916.66 – 948.42
- 52-week range
- 591.52 – 991.73
- 52-week change
- +21.80%
- 50-day moving average
- 829.76
- 200-day moving average
- 751.41
- Beta
- —
- Volume
- 877.67K
- Average volume
- 805.45K
Dividends and events
- Annual dividend
- $3.70
- Dividend yield
- 0.40%
- Next earnings date
- Oct 30, 2026
Additional statistics
- Market Cap
- 95.24B
- Pe
- 20.35
- Forward Pe
- 12.85
- Eps
- 45.24
- Dividend Yield
- 41.00%
- Dividend Rate
- 3.70
- Week52 High
- 991.73
- Week52 Low
- 591.52
- Avg Volume
- 805.45K
- Shares Outstanding
- 101.63M
- Ma50
- 829.76
- Ma200
- 751.41
- Earnings Date
- Oct 30, 2026
- Pct From52w High
- -7.16%
- Pct From52w Low
- 55.65%